2020 American Transplant Congress » Poster Session C: Kidney Immunosuppression: Induction Therapy

3:30pm-4:00pm

Anti-T Lymphocyte Immunoglobulins versus Basiliximab in Highly Sensitized Kidney-Transplant Patients without Preformed DSAs: The Satir Study

N. Kamar¹, L. Couzi², L. Albano³, A. Durrbach⁴, V. Pernin⁵, L. Esposito¹, M. Lequintrec⁵, P. Merville², A. Del Bello¹

3:30pm-4:00pm

Basiliximab Induction in the Obese: One Size Does Fit All

A. D. Reticker¹, D. Choi¹, A. B. Lichvar¹, C. Kane², I. Tzvetanov³, E. Benedetti³, J. J. Benken¹

3:30pm-4:00pm

Enough Initial Tacrolimus Blood Concentration is Crucial Even with Additional Everolimus in Corticosteroid Early Withdrawal Regimen for Kidney Transplant Recipients

H. Sasaki¹, T. Tanabe¹, H. Higuchi¹, T. Tsujimoto², H. Harada¹

3:30pm-4:00pm

Evaluation of the Ability of the Integrative Box (ibox) to Predict Kidney Allograft Survival in a Cohort of Brazilian Patients

K. Linhares¹, M. Raynaud², O. Aubert², C. Lefaucher², G. Gomes¹, C. Peixoto¹, L. Villanueva¹, C. Legendre³, A. Loupy², H. Tedesco-Silva¹

3:30pm-4:00pm

High PRA Increases Rejection but Does Not Worsen Renal Function in the First Year Post Kidney Transplant with Alemtuzumab Induction

B. Wise, A. Freeman, M. Janusek, S. Anders, L. Hutchinson, U. Kaszubski, D. Marroquin, D. Martin, H. Bohorquez

3:30pm-4:00pm

Induction Therapy with Basiliximab versus Thymoglobulin in African-American Kidney Transplant Recipients in the Current Era of Immunosuppression

M. Zachariah¹, I. Mallawaarachchi², N. Meeks³, D. Wright¹, R. Minawala¹, V. Liu¹, J. Rolls⁴, S. Hussein⁴, C. Jarrin⁵

3:30pm-4:00pm

Renal Transplant Induction Therapy Safety Outcomes Comparison

R. M. Hofmann¹, J. Combs², K. J. Schmidt³, T. Dyckman⁴

3:30pm-4:00pm

Safety and Efficacy of Low Dose Rabbit Antithymocyte Globulin in Pediatric Renal Transplant Recipients

V. K. Sigurjonsdottir¹, L. Maestretti¹, A. McGrath¹, A. Gallo², W. Concepcion², P. Grimm¹, A. Chaudhuri¹

3:30pm-4:00pm

The Challenge of Selecting an Induction Agent: A Dual Regimen for Medically High-Risk Kidney Recipients

R. Craig-Schapiro, B. Magaoay, R. Grover, S. Sultan, M. Aull, S. Kapur

3:30pm-4:00pm

Torc1 Inhibition Protects Activated Human Regulatory T Cells from Self-Inflicted Damage via Granzyme B

J. B. Alhaddad, H. Allos, B. S. Al Dulaijan,, S. K. Eskandari, I. Sulkaj, G. Melhem, J. Y. Choi, J. R. Azzi